Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from SSY Group ( (HK:2005) ) is now available.
SSY Group Limited announced that 12 of its products with 14 specifications were selected in the eleventh batch of the National Centralised Medicines Procurement in China. This selection is a significant development for the company, potentially enhancing its market presence and operational growth in the pharmaceutical industry, while also informing shareholders and potential investors of its latest business achievements.
The most recent analyst rating on (HK:2005) stock is a Buy with a HK$3.50 price target. To see the full list of analyst forecasts on SSY Group stock, see the HK:2005 Stock Forecast page.
More about SSY Group
SSY Group Limited operates in the pharmaceutical industry, focusing on the production and distribution of a wide range of medicinal products. The company is involved in the development and supply of various pharmaceutical formulations, catering to the healthcare needs in China.
Average Trading Volume: 14,575,584
Technical Sentiment Signal: Hold
Current Market Cap: HK$9.09B
For detailed information about 2005 stock, go to TipRanks’ Stock Analysis page.